lycorine has been researched along with Angiogenesis, Pathologic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Li, X; Lv, F; Wang, Y | 1 |
| Bao, M; Cao, Z; Liu, R; Pan, Y; Shang, B; Tu, J; Yang, P; Zhang, G; Zhang, S; Zhou, Q | 1 |
| Bao, M; Cao, Z; Fu, S; Guo, P; Pan, Y; Shang, B; Tu, J; Yang, P; Yu, D; Zhang, G; Zhou, Q | 1 |
3 other study(ies) available for lycorine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Lycorine inhibits angiogenesis by docking to PDGFRα.
Topics: Amaryllidaceae Alkaloids; Angiogenesis Inhibitors; Cell Proliferation; Human Umbilical Vein Endothelial Cells; Humans; Molecular Docking Simulation; Neoplasms; Neovascularization, Pathologic; Phenanthridines; Receptor, Platelet-Derived Growth Factor alpha; Sunitinib | 2022 |
Lycorine hydrochloride inhibits metastatic melanoma cell-dominant vasculogenic mimicry.
Topics: Amaryllidaceae Alkaloids; Animals; Antigens, CD; Cadherins; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Melanoma; Mice; Models, Biological; Neoplasm Metastasis; Neovascularization, Pathologic; Phenanthridines; Promoter Regions, Genetic; Skin Neoplasms | 2012 |
Lycorine hydrochloride selectively inhibits human ovarian cancer cell proliferation and tumor neovascularization with very low toxicity.
Topics: Amaryllidaceae Alkaloids; Animals; Antigens, CD; Antineoplastic Agents; Apoptosis; Cadherins; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin D3; Down-Regulation; Female; Humans; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Ovarian Neoplasms; Phenanthridines; Phosphorylation; Proto-Oncogene Proteins c-akt; Semaphorins | 2013 |